SMT201700055B - Composti per il trattamento di malattie correlate a ischemia-riperfusione - Google Patents

Composti per il trattamento di malattie correlate a ischemia-riperfusione

Info

Publication number
SMT201700055B
SMT201700055B SM201700055T SM201700055T SMT201700055B SM T201700055 B SMT201700055 B SM T201700055B SM 201700055 T SM201700055 T SM 201700055T SM 201700055 T SM201700055 T SM 201700055T SM T201700055 B SMT201700055 B SM T201700055B
Authority
SM
San Marino
Prior art keywords
reperfusion
ischemia
compounds
treatment
related diseases
Prior art date
Application number
SM201700055T
Other languages
English (en)
Inventor
Antonio Guarna
Federico Cozzolino
Original Assignee
Minerva Patents S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Patents S A filed Critical Minerva Patents S A
Publication of SMT201700055B publication Critical patent/SMT201700055B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • External Artificial Organs (AREA)
SM201700055T 2012-03-21 2017-01-25 Composti per il trattamento di malattie correlate a ischemia-riperfusione SMT201700055B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000062A ITFI20120062A1 (it) 2012-03-21 2012-03-21 Componenti per il trattamento di malattie correlate a ischemia-riperfusione.
PCT/IB2013/052205 WO2013140348A1 (en) 2012-03-21 2013-03-20 Compounds for the treatment of ischemia-reperfusion- related diseases

Publications (1)

Publication Number Publication Date
SMT201700055B true SMT201700055B (it) 2017-03-08

Family

ID=46147570

Family Applications (2)

Application Number Title Priority Date Filing Date
SM20170055T SMT201700055T1 (it) 2012-03-21 2013-03-20 Composti per il trattamento di malattie correlate a ischemia-riperfusione
SM201700055T SMT201700055B (it) 2012-03-21 2017-01-25 Composti per il trattamento di malattie correlate a ischemia-riperfusione

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SM20170055T SMT201700055T1 (it) 2012-03-21 2013-03-20 Composti per il trattamento di malattie correlate a ischemia-riperfusione

Country Status (24)

Country Link
US (2) US9932352B2 (it)
EP (1) EP2855487B1 (it)
JP (2) JP6382791B2 (it)
KR (2) KR20150014910A (it)
CN (1) CN104395321B (it)
AU (2) AU2013237021B2 (it)
CA (1) CA2907652C (it)
CY (1) CY1118282T1 (it)
DK (1) DK2855487T3 (it)
EA (1) EA033160B1 (it)
ES (1) ES2601384T3 (it)
HR (1) HRP20161436T1 (it)
HU (1) HUE031535T2 (it)
IL (1) IL234796B (it)
IN (1) IN2014CH07744A (it)
IT (1) ITFI20120062A1 (it)
LT (1) LT2855487T (it)
ME (1) ME02553B (it)
PL (1) PL2855487T3 (it)
PT (1) PT2855487T (it)
RS (1) RS55337B1 (it)
SI (1) SI2855487T1 (it)
SM (2) SMT201700055T1 (it)
WO (1) WO2013140348A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
IT202000008125A1 (it) * 2020-04-16 2021-10-16 Minerva Srl Acidi carbossilici 3-aza-biciclo[3.2.1]ottani e loro derivati per l’uso nel trattamento di infiammazioni
IT202200016614A1 (it) 2022-08-04 2024-02-04 Mimetech S R L Udonitrectag e sue formulazioni ad uso topico per l’uso nel trattamento di patologie dermatologiche

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75910B (it) 1981-04-21 1984-08-02 Delalande Sa
DE60042585D1 (de) 2000-02-29 2009-09-03 Univ Firenze 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken
ITFI20020107A1 (it) * 2002-06-19 2003-12-19 Antonio Guarna Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti
AP2005003196A0 (en) * 2002-07-18 2005-03-31 Pfizer Prod Inc Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor.
WO2006015183A2 (en) * 2004-07-30 2006-02-09 Axonyx, Inc. Pharmaceutical compositions for treating disorders of the skin
ES2380613T3 (es) * 2008-11-25 2012-05-16 Universita' Degli Studi Di Firenze Inhibidores peptidomiméticos bicíclicos de aspartil-proteasas para el tratamiento de enfermedades infecciosas

Also Published As

Publication number Publication date
JP2015514069A (ja) 2015-05-18
KR20150014910A (ko) 2015-02-09
LT2855487T (lt) 2016-11-25
EA201401045A1 (ru) 2015-03-31
ES2601384T3 (es) 2017-02-15
EP2855487A1 (en) 2015-04-08
EP2855487B1 (en) 2016-08-03
HRP20161436T1 (hr) 2017-01-13
IL234796B (en) 2018-02-28
US20150080388A1 (en) 2015-03-19
US20180155363A1 (en) 2018-06-07
AU2017265037A1 (en) 2017-12-07
EA033160B1 (ru) 2019-09-30
US9932352B2 (en) 2018-04-03
JP2018168173A (ja) 2018-11-01
SMT201700055T1 (it) 2017-03-08
CN104395321B (zh) 2017-05-03
CA2907652A1 (en) 2013-09-26
KR20200049912A (ko) 2020-05-08
DK2855487T3 (en) 2016-12-05
AU2013237021B2 (en) 2017-08-24
ITFI20120062A1 (it) 2013-09-22
HUE031535T2 (en) 2017-07-28
CA2907652C (en) 2021-03-16
PL2855487T3 (pl) 2017-02-28
IN2014CH07744A (it) 2016-07-01
CN104395321A (zh) 2015-03-04
ME02553B (me) 2017-02-20
PT2855487T (pt) 2016-12-20
RS55337B1 (sr) 2017-03-31
AU2017265037B2 (en) 2018-03-15
JP6382791B2 (ja) 2018-08-29
CY1118282T1 (el) 2017-06-28
WO2013140348A1 (en) 2013-09-26
AU2013237021A1 (en) 2014-11-13
SI2855487T1 (sl) 2017-05-31
KR102181346B1 (ko) 2020-11-23

Similar Documents

Publication Publication Date Title
IL289300A (en) Combination therapy for treating cancer
HUE046790T2 (hu) A rák kezelésének módszerei
LT2707030T (lt) Vėžio gydymas
HUE043171T2 (hu) Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek
DK2827710T3 (da) Doseringsskema for echinocandin-klasse-forbindelser
HUE041882T2 (hu) Lipidek terápiás szer bevitelére szolgáló formulákhoz
PL2739153T3 (pl) Leczenie raka sutka
PL2776416T3 (pl) Związki farmaceutyczne
IL230657A0 (en) Compounds for the treatment of addiction
HUE046667T2 (hu) Rák kombinatív kezelése
GB201119799D0 (en) Pharmaceutical compounds
IL250725A0 (en) Difluorolactam formulations for ep4-mediated bone-related conditions and diseases
ZA201403832B (en) Pharmaceutical compounds
IL229081A0 (en) Isoxazolines as therapeutic agents
GB201116767D0 (en) Treatment for mitrochondrial neurogastrointestinal encephalomyopathy
GB201118876D0 (en) Pharmaceutical compounds
CO6880064A2 (es) Métodos terapéuticos
GB201113163D0 (en) Pharmaceutical compounds
SMT201700055B (it) Composti per il trattamento di malattie correlate a ischemia-riperfusione
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
DK2694056T3 (da) Terapeutisk behandling
IL236873A0 (en) therapeutic compounds
FI20115622A7 (fi) Virikeväline
ES1075781Y (es) Sofa-cama modular
ES1075603Y (es) Objeto terapeutico